SSBP2 variants are associated with survival in glioblastoma patients

Clinical Cancer Research

Volumn 18, Issue 11, 2012, Pages 3154-3162

  Xiao, Yuanyuan ^a   Decker, Paul A ^c   Rice, Terri ^a   McCoy, Lucie S ^a   Smirnov, Ivan ^a   Patoka, Joseph S ^a   Hansen, Helen M ^a   Wiemels, Joe L ^a,b   Tihan, Tarik ^a   Prados, Michael D ^a   Chang, Susan M ^a   Berger, Mitchel S ^a   Kosel, Matthew L ^c   Fridley, Brooke L ^c   Lachance, Daniel H ^c   O'Neill, Brian Patrick ^c   Buckner, Jan C ^c   Thompson, Reid C ^d   Nabors, Louis Burt ^e   Olson, Jeffrey J ^f   Brem, Steve ^h   Madden, Melissa H ^g   Browning, James E ^g   Wiencke, John K ^a,b   Egan, Kathleen M ^g   Jenkins, Robert B ^c   Wrensch, Margaret R ^a,b   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mayo Clinic   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLIOBLASTOMA; HEALTH CARE QUALITY; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRANDED DNA BINDING PROTEIN 2 GENE;

BRAIN NEOPLASMS; DACARBAZINE; DNA-BINDING PROTEINS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84861782261     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-2778     Document Type: Article

References (32)

1. Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst 2011;103:817-25.
2. Andersson U, Osterman P, Sjostrom S, Johansen C, Henriksson R, Brannstrom T, et al. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer 2009;125:968-72.
3. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 2004;64:1220-3. (Pubitemid 38235584)
4. Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol 2010;28:2467-74.
5. Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G, et al. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 2004;10:2618-25. (Pubitemid 38509134)
6. Scheurer ME, Amirian E, Cao Y, Gilbert MR, Aldape KD, Kornguth DG, et al. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin Cancer Res 2008;14:6640-6.
7. Sjostrom S, Andersson U, Liu Y, Brannstrom T, Broholm H, Johansen C, et al. Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro Oncol 2010;12:815-21.
8. Sjostrom S, Wibom C, Andersson U, Brannstrom T, Broholm H, Johansen C, et al. Genetic variations in VEGF and VEGFR2 and glioblastoma outcome. J Neurooncol 2010;104:523-7.
9. Wang L, Wei Q, Wang LE, Aldape KD, Cao Y, Okcu MF, et al. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 2006;24:1627-32. (Pubitemid 46638787)
10. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009;41: 905-8.
11. Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 2011;104:535-42.
12. Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, Rice T, et al. Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 2009;20:87-96.
13. Wrensch M, McMillan A, Wiencke J, Wiemels J, Kelsey K, Patoka J, et al. Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin Cancer Res 2007;13:197-205. (Pubitemid 46121869)
14. Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, et al. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst 2011;103: 143-53.
15. Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, et al. Molecular features of adult glioma associated with patient race/ ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev 2005;14: 1774-83. (Pubitemid 40995094)
16. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006;66:4531-41.
17. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-8.
18. Cochran WG. The combination of estimates from different experiments. Biometrics. Washington, DC: International Biometric Society; 1954. p. 101-29.
19. Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999;18:321-59.
20. Lee Y, Scheck AC, Cloughesy TF, Lai A, Dong J, Farooqi HK, et al. Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genomics 2008;1:52.
21. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008;26:3015-24.
22. Verhaak RG, Hoadley KA, Purdom E,WangV, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
23. Huse JT, Phillips HS, Brennan CW. Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia 2011;59:1190-9.
24. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-34.
25. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34. (Pubitemid 28562978)
26. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010; 17:510-22.
27. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, Cotsapas C, et al. Genome-wide detection and characterization of positive selection in human populations. Nature 2007;449:913-8.
28. Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, et al. Amultigene predictor of outcome in glioblastoma. Neuro Oncol 2010;12:49-57.
29. Huang Y, Chang X, Lee J, Cho YG, Zhong X, Park IS, et al. Cigarette smoke induces promoter methylation of single-stranded DNA-binding protein 2 in human esophageal squamous cell carcinoma. Int J Cancer 2011;128:2261-73.
30. Liang H, Samanta S, Nagarajan L. SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells. Oncogene 2005;24:2625-34. (Pubitemid 40593090)
31. Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, et al. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS One 2011;6:e17014.
32. Shaw EJ, Haylock B, Husband D, du Plessis D, Sibson DR, Warnke PC, et al. Gene expression in oligodendroglial tumors. Anal Cell Pathol (Amst) 2010;33:81-94.